Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changlu Liu

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|June 28, 2008
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)Jessica Zhu, Chester Kuei, Steven Sutton, et al.
European Journal of Pharmacology|May 3, 2005
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dogPascal Bonaventure, Diane Nepomuceno, Kirsten Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2004
Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian speciesJingcai Chen, Chester Kuei, Steven W Sutton, et al.
The Journal of Biological Chemistry|October 3, 2003
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135Changlu Liu, Elo Eriste, Steven Sutton, et al.
Plos One|June 6, 2024
Retraction: The PAR2 signal peptide prevents premature receptor cleavage and activationBelinda Liu, Grace Lee, Jiejun Wu, et al.
Plos One|February 21, 2020
The PAR2 signal peptide prevents premature receptor cleavage and activationBelinda Liu, Grace Lee, Jiejun Wu, et al.
BMC Pulmonary Medicine|October 24, 2020
IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cellsLing Gong, Gang Liu, Honglan Zhu, et al.
Pharmacology Research & Perspectives|February 19, 2019
Mutagenesis of GPR139 reveals ways to create gain or loss of function receptorsLien Wang, Grace Lee, Amy Shih, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous systemSteven W Sutton, Jonathan Shelton, Craig Smith, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|June 28, 2008
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)Jessica Zhu, Chester Kuei, Steven Sutton, et al.
European Journal of Pharmacology|May 3, 2005
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dogPascal Bonaventure, Diane Nepomuceno, Kirsten Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2004
Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian speciesJingcai Chen, Chester Kuei, Steven W Sutton, et al.
The Journal of Biological Chemistry|October 3, 2003
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135Changlu Liu, Elo Eriste, Steven Sutton, et al.
Plos One|June 6, 2024
Retraction: The PAR2 signal peptide prevents premature receptor cleavage and activationBelinda Liu, Grace Lee, Jiejun Wu, et al.
Plos One|February 21, 2020
The PAR2 signal peptide prevents premature receptor cleavage and activationBelinda Liu, Grace Lee, Jiejun Wu, et al.
BMC Pulmonary Medicine|October 24, 2020
IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cellsLing Gong, Gang Liu, Honglan Zhu, et al.
Pharmacology Research & Perspectives|February 19, 2019
Mutagenesis of GPR139 reveals ways to create gain or loss of function receptorsLien Wang, Grace Lee, Amy Shih, et al.
Annals of the New York Academy of Sciences|May 7, 2009
Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous systemSteven W Sutton, Jonathan Shelton, Craig Smith, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 ReceptorCurt A Dvorak, Heather Coate, Diane Nepomuceno, et al.
Pageof 7